Are you over 18 and want to see adult content?
More Annotations
A complete backup of redleafpress.org
Are you over 18 and want to see adult content?
A complete backup of tosohbioscience.com
Are you over 18 and want to see adult content?
A complete backup of princeofpinot.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of knowtechtoday.com
Are you over 18 and want to see adult content?
A complete backup of counsellingresource.com
Are you over 18 and want to see adult content?
A complete backup of auktionshuset.com
Are you over 18 and want to see adult content?
A complete backup of trainingcoursematerial.com
Are you over 18 and want to see adult content?
Text
HCL INOTES LOGIN
Licensed Materials © Copyright HCL Technologies. 1985, 2019. Java and all Java-based trademarks and logos are trademarks or registered trademarks of Oracle and/or BMC REMEDY MID TIER 9.1 SUN PHARMA IT SERVICE MANAGEMENT. A gateway to IT Service offerings managed by Sun Pharma: SELF SERVICE MADE-EASY: ONE-CONNECT - Access to IT Services is just a two taps away - CREDENTIAL ADMINISTRATOR Are you registered user? If No, login to register yourself for using Password Reset, Account Unlock option. サンファーマ株式会社 サンファーマについて. サンファーマは、2012年3月、日本における医療用医薬品の開発、製造及び販売、並びに医薬品原料(api)及び中間体の製造、販売を目的として設立されました。PRAGATI
Mail us for support at CNF.Helpdesk@sunpharma.com | © Sun Pharmaceutical Industries Limited医療機関 各位
2021年4月 医療機関 各位 製造販売: 販 売: サンファーマ株式会社 田辺三菱製薬株式会社 福島県沖を震源とする地震の影響に関するお詫び SUN PHARMACEUTICAL INDUSTRIES LIMITED & ITS SUBSIDIARIESCANADAABOUTBUSINESS DEVELOPMENTCONTACTSRI LANKADISCLAIMER As a Company of repute and global standing, Sun Pharma is committed to conducting its business by adopting the highest standards of professional integrity and ethical behavior. CANADA - SUN PHARMACEUTICAL INDUSTRIES LTD. Contact. Sun Pharma Canada Inc., 126 East Drive, Brampton, ON L6T 1C1, Canada. 1-866-840-1340 1-905-790-5199 canadacustomerservice@sunpharma.com OUR PRIORITY & RESPONSIBILITY Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation. ANNUAL REPORTS PRESENTATIONS At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns. OUR PRODUCT PORTFOLIO Over-the-Counter Medications. We provide a range of over-the-counter (OTC) / consumer healthcare products. Faringosept (sore throat), Revital (vitamins) and Volini (topical analgesics) are a few of our flagship OTC brands that are marketed in several countries globally. There are other category defining brands such as Coldact & Flustat (cold & flu), Brustan, Painamol & Paduden (analgesics OUR INVESTOR INFORMATION At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.COVID-19 RESPONSE
We made donations of COVID-19 specific medicines, hand sanitizers and PPEs in countries across the globe. In India, we donated INR 250 Million (Indian Rupees Two Hundred and Fifty Million) of Hydroxychloroquine (HCQS), Azithromycin, other related drugs and handsanitizers.
INVESTOR INFORMATION & PRESENTATIONS At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns. INDIA - SUN PHARMACEUTICAL INDUSTRIES LTD. Contact. Sun Pharmaceutical Industries Ltd., SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063. Tel : (+9122) 4324 4324
MOROCCO - SUN PHARMACEUTICAL INDUSTRIES LTD. Contact. Ranbaxy Morocco LLC, a SUN PHARMA company, 219, Boulevard Zerktouni, Angle Boulevard Roudani, Etage 5, 20330 El Maârif-Casablanca. Morocco +212 522 20 49 81 SRI LANKA - SUN PHARMACEUTICAL INDUSTRIES LTD. Hemas Pharmaceuticals (Pvt) Ltd. No: 12, Glen Aber Pl, Colombo 00300 Sri Lanka +94114766666 Ext: 3618 sunpharma@hemas.com HOME - SUN PHARMA USA Sun Pharmaceutical Industries Inc., 2 Independence Way, Princeton, NJ 08540 (609)720-9200 (609)514-1155. General Information (Customers Contact) info.unitedstates@sunpharma.com SUN PHARMACEUTICAL INDUSTRIES LIMITED : VENDORS -- POWERED Welcome to Sun Pharmaceutical Industries Limited e-Business Portal:Username. Password
FRANCE - SUN PHARMACEUTICAL INDUSTRIES LTD. Contact. Sun Pharma France, Immeuble Avant Seine, 11-15 Quai de Dion Bouton, 92816 PUTEAUX Cedex, FRANCE + 33 (0)1 41 44 44 50 + 33 (0)1 41 44 44 90 contact.france@sunpharma.com SUN PHARMACEUTICAL INDUSTRIES LIMITED & ITS SUBSIDIARIESCANADAABOUTBUSINESS DEVELOPMENTCONTACTSRI LANKADISCLAIMER Sun Pharma @SunPharma_Live ·. 24 Apr 1385836694818095105. There are many people like Jamuna Bai Nagesh, who have benefited by our Malaria Elimination Demonstration Project in Mandla, MP. In our fight against malaria, we drove early diagnosis & treatment, increased usage of bednets & awareness drives for the community. CANADA - SUN PHARMACEUTICAL INDUSTRIES LTD. Contact. Sun Pharma Canada Inc., 126 East Drive, Brampton, ON L6T 1C1, Canada. 1-866-840-1340 1-905-790-5199 canadacustomerservice@sunpharma.com OUR PRODUCT PORTFOLIO Our product portfolio includes generics, branded generics, speciality, difficult-to-make technology intensive products, over-the-counter (OTC), anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates. Our presence in more than 100 countries helps us in being responsive to local treatment needs whilecontinually
OUR INVESTOR INFORMATION Our Investor Information | Sun Pharmaceutical Industries Limited. Investor Information. At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns. OUR PRIORITY & RESPONSIBILITY Environment, Health and Safety. At Sun Pharma, we remain fully committed to achieving excellence through our Environmental, Health & Safety (EHS) programmes. Conducting our activities in a responsible, proactive manner is a core focus of our operations and culture. As a part of this commitment, our EHS Policy provides for the creation of asafe
ANNUAL REPORTS PRESENTATIONS Annual Reports Presentations | Sun Pharmaceutical Industries Limited. Investor Information. At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.HCL INOTES LOGIN
This Program is licensed under the terms of the license agreement accompanying the Program. This license agreement may be either located in a Program directory folder or library identified as "License", if applicable, or provided as a printed license agreement. Please read this agreement carefully before using the Program. By using theProgram
BMC REMEDY MID TIER 9.1 SUN PHARMA IT SERVICE MANAGEMENT. A gateway to IT Service offerings managed by Sun Pharma: SELF SERVICE MADE-EASY: ONE-CONNECT - Access to IT Services is just a two taps away -PRAGATI
Mail us for support at CNF.Helpdesk@sunpharma.com | © Sun Pharmaceutical Industries Limited サンファーマ株式会社 サンファーマ株式会社(Sun Pharma Japan Ltd.). 〒141-0031 東京都品川区西五反田8-9-5 FORECAST五反田WEST. Tel. : 03-5719-6663. お問い合わせ (代表) inquiry.japan@sunpharma.com. SUN PHARMACEUTICAL INDUSTRIES LIMITED & ITS SUBSIDIARIESCANADAABOUTBUSINESS DEVELOPMENTCONTACTSRI LANKADISCLAIMER Sun Pharma @SunPharma_Live ·. 24 Apr 1385836694818095105. There are many people like Jamuna Bai Nagesh, who have benefited by our Malaria Elimination Demonstration Project in Mandla, MP. In our fight against malaria, we drove early diagnosis & treatment, increased usage of bednets & awareness drives for the community. CANADA - SUN PHARMACEUTICAL INDUSTRIES LTD. Contact. Sun Pharma Canada Inc., 126 East Drive, Brampton, ON L6T 1C1, Canada. 1-866-840-1340 1-905-790-5199 canadacustomerservice@sunpharma.com OUR PRODUCT PORTFOLIO Our product portfolio includes generics, branded generics, speciality, difficult-to-make technology intensive products, over-the-counter (OTC), anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates. Our presence in more than 100 countries helps us in being responsive to local treatment needs whilecontinually
OUR INVESTOR INFORMATION Our Investor Information | Sun Pharmaceutical Industries Limited. Investor Information. At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns. OUR PRIORITY & RESPONSIBILITY Environment, Health and Safety. At Sun Pharma, we remain fully committed to achieving excellence through our Environmental, Health & Safety (EHS) programmes. Conducting our activities in a responsible, proactive manner is a core focus of our operations and culture. As a part of this commitment, our EHS Policy provides for the creation of asafe
ANNUAL REPORTS PRESENTATIONS Annual Reports Presentations | Sun Pharmaceutical Industries Limited. Investor Information. At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.HCL INOTES LOGIN
This Program is licensed under the terms of the license agreement accompanying the Program. This license agreement may be either located in a Program directory folder or library identified as "License", if applicable, or provided as a printed license agreement. Please read this agreement carefully before using the Program. By using theProgram
BMC REMEDY MID TIER 9.1 SUN PHARMA IT SERVICE MANAGEMENT. A gateway to IT Service offerings managed by Sun Pharma: SELF SERVICE MADE-EASY: ONE-CONNECT - Access to IT Services is just a two taps away -PRAGATI
Mail us for support at CNF.Helpdesk@sunpharma.com | © Sun Pharmaceutical Industries Limited サンファーマ株式会社 サンファーマ株式会社(Sun Pharma Japan Ltd.). 〒141-0031 東京都品川区西五反田8-9-5 FORECAST五反田WEST. Tel. : 03-5719-6663. お問い合わせ (代表) inquiry.japan@sunpharma.com. CANADA - SUN PHARMACEUTICAL INDUSTRIES LTD. Contact. Sun Pharma Canada Inc., 126 East Drive, Brampton, ON L6T 1C1, Canada. 1-866-840-1340 1-905-790-5199 canadacustomerservice@sunpharma.com OUR INVESTOR INFORMATION Our Investor Information | Sun Pharmaceutical Industries Limited. Investor Information. At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.COVID-19 RESPONSE
Barcitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). The drug is approved by the Indian drug regulator, CDSCO for restricted emergency use inIndia.
OUR GLOBAL QUALITY
Quality Management System. We follow one quality standard globally at Sun. We ensure its implementation across different functions, including research & development, quality and technical operations. The Global Quality Manual covers all the quality system elements of the QMS as they are applicable throughout our lines of business. SUN PHARMA REPORTS Q4FY21 RESULTS Sun Pharmaceutical Industries Limited SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343 MOROCCO - SUN PHARMACEUTICAL INDUSTRIES LTD. a SUN PHARMA company, 219, Boulevard Zerktouni, Angle Boulevard Roudani, Etage 5, 20330 El Maârif-Casablanca. Morocco. +212 522 20 49 81. +212 522 20 40 59. shailesh.somvanshi@sunpharma.com. HOME - SUN PHARMA USA Billerica, MA 01821. Sun Pharmaceutical Industries Inc., 1 Commerce Drive, Cranbury, NJ 08512. (609) 819-8200. (609) 655-7448. Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. SRI LANKA - SUN PHARMACEUTICAL INDUSTRIES LTD. Hemas Pharmaceuticals (Pvt) Ltd. No: 12, Glen Aber Pl, Colombo 00300 Sri Lanka +94114766666 Ext: 3618 sunpharma@hemas.comSUNPHARMA.COM
sunpharma.com
INVESTOR UPDATE CALL TRANSCRIPT FY19 Investor update Call Transcript -03 Dec 18.pdf. Released Date: Thursday, December 27, 2018* HOME
* ABOUT
* OPERATIONS
* PRODUCTS
* RESPONSIBILITY
* INVESTORS
* MEDIA
* CAREERS
* BUSINESS DEVELOPMENT* CONTACT
* GLOBAL PRESENCE
* ABOUT
* Milestones
* Board of Directors * Acquisitions & Joint Ventures * Awards & Accreditations* OPERATIONS
* Research & Development* Manufacturing
* Quality
* PRODUCTS
* Formulations
* Active Pharmaceutical Ingredients* OTC
* RESPONSIBILITY
* CSR
* EHS
* HIV/AIDS
* Anti-Malaria
* CSR
* Ranbaxy Community Healthcare Society * Ranbaxy - Daiichi Sankyo Joint Initiative * Ranbaxy Science Foundation* INVESTORS
* Financials
* Annual Reports & Presentation * Shareholder's Information* Investors FAQs
* Archives
* Shareholder's Information* Stock Information
* Dividend history
* Unclaimed Dividend * Statutory Communications * Our Policies And Codes* Tools
* Archives
* Sun Pharma - Ranbaxy Merger* Ranbaxy Archives
* Ranbaxy Archives
* Quarterly Results
* Annual Reports
* Corporate Governance* Presentations
* Share Holding Pattern * Unclaimed Dividend* MEDIA
* Press Releases
* In the News
* Media Kit
* CAREERS
* Work with us
* Life @ Sun Pharma
* Academic Programmes* GLOBAL PRESENCE
* AFRICA
* ASIA PACIFIC
* EUROPE
* NORTH AMERICA
* SOUTH AMERICA
* CIS
* AFFILIATED WEBSITES* AFRICA
* Morocco
* Nigeria
* South Africa
* ASIA PACIFIC
* Australia
* Malaysia
* Myanmar
* Sri Lanka
* EUROPE
* France
* Germany
* Ireland
* Italy
* Lithuania
* The Netherlands
* Poland
* Romania
* Spain
* United Kingdom
* Denmark
* Finland
* Norway
* NORTH AMERICA
* Canada
* USA
* SOUTH AMERICA
* Brazil
* CIS
* Russia
* Ukraine
* AFFILIATED WEBSITES * Taro Pharmaceutical Industries Limited * Dusa Pharmaceuticals Skip to main content* Home
* Business Development* Products
* Contact
* A-
* A
* A+
__ GLOBAL PRESENCE
*
*
AFRICA
* Morocco
* Nigeria
* South Africa
*
ASIA PACIFIC
* Australia
* Japan
* Malaysia
* Myanmar
* Sri Lanka
*
EUROPE
* France
* Germany
* Ireland
* Italy
* Lithuania
* The Netherlands
* Poland
* Romania
* Spain
* United Kingdom
* Denmark
* Finland
* Hungary
* Norway
* Sweden
* Switzerland
*
NORTH AMERICA
* Canada
* USA
*
SOUTH AMERICA
* Brazil
*
CIS
* Russia
* Ukraine
*
AFFILIATED WEBSITES
* Taro Pharmaceutical Industries Limited * Dusa Pharmaceuticals* __About Us
*
* Milestones
*
* Vision & Values
*
* Board of Directors*
* Acquisitions & Joint Ventures*
* Awards & Accreditations* __Operations
*
* Research & Development*
* Manufacturing
*
* Quality
* __Responsibility
*
* CSR
*
* EHS
*
* HIV/AIDS
* __Investors
*
* Financials
*
* Annual Reports & Presentations*
* ANNUAL REPORT OF SUBSIDIARY COMPANIES*
* Shareholder's Information*
* Archives
* __Media
*
* Press Releases
*
* Media Kit
* __Careers
*
* Work with us
*
* Life @ Sun Pharma
EVOLUTION OF SUN
_From humble beginnings __ in 1983_
_to a brand trusted worldwide_WATCH OUR VIDEO
WORLD's 4th LARGEST
_Speciality Generic_ PHARMACEUTICAL COMPANY READ ABOUT SUN PHARMA _We Develop High-Quality,_ AFFORDABLE MEDICINES TRUSTED BY _Healthcare Professionals & Patients_ IN 100 COUNTRIES ACROSS SIX CONTINENTS READ ABOUT OUR PRODUCTS _Our Product offerings_ HAVE THE HALLMARK OF_Technology-Based_
DIFFERENTIATION
READ ABOUT OUR R&D
_Our multi-cultural team_OF MORE THAN
30,000 EMPLOYEES
_is our most_
VALUABLE ASSET
READ ABOUT OUR CULTURE _Our Passion for Quality_ GOES BEYOND BUSINESS _Putting Patients First_IS OUR MOTTO
READ ABOUT OUR QUALITY*
>40 _manufacturing
sites_ View our Manufacturing Sites*
>100 _markets
served_ Explore Our Global Operations*
>2000 _marketed
products_ Explore our products*
>30,000 _employees
WORLDWIDE_
Go to Careers
FINANCIAL UPDATES
03 OCT
FY20 Q1 Financial Result - Transcript13 AUG
FY20 Q1 Financial Results13 AUG
FY20 Q1 Financial Press ReleaseRead More
PRESS RELEASES
24 OCT
Sun Pharma to announce second quarter results on 07 November 201916 OCT
Sun Pharma Launches Drizalma Sprinkle in the US14 OCT
Sun Pharma Launches CEQUA for the Treatment of Dry Eye Disease in theUS
Read More
* Board of Directors * Acquisitions & Joint Ventures * Awards & Accreditations * Adverse Event Reporting * Research & Development* Manufacturing
* Products
* Quality
* Responsibility
* Sun Pharma - Ranbaxy Merger* Ranbaxy Archives
* Annual Reports
* Investors Relations* Media Kit
* Press Releases
* Sitemap
* Employee Portal
* Vendors Portal
* Field Staff Portal * U.S. Healthcare Compliance Program Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma's acquisition of Ranbaxy. If you wish to learn more about the program, please clickContinue .
Copyright © Sun Pharmaceutical Industries Ltd. Privacy Policy | Disclaimer* YouTube
* Linkdin
Site Credits
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0